Sernova Breaks New Ground in Islet Cell Transplantation

By Catherine ShafferStaff Writer

Thursday, August 16, 2012

Sernova Corp., of London, Ontario, is taking islet cell transplantation to the next level by combining transplanted insulin-producing islet cells with its Cell Pouch device in a Phase I/II trial in patients with Type I diabetes.